Brian Burkavage - May 31, 2022 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Role
Chief Accounting Officer
Signature
/s/ Brian Burkavage
Stock symbol
IOBT
Transactions as of
May 31, 2022
Transactions value $
$0
Form type
4
Date filed
6/2/2022, 06:25 PM
Previous filing
May 13, 2022
Next filing
Mar 22, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IOBT Stock Option (Right to Buy) Award $0 +20K $0.00 20K May 31, 2022 Common Stock 20K $4.83 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of these options vest on 5/31/2023, and 1/48th of these options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause within 24 months of a change of control.